Article Text

INFORMED CONSENT AND PARENTAL COMPREHENSION IN PAEDIATRIC CLINICAL TRIALS: A PROSPECTIVE STUDY ON CHILDHOOD LEUKAEMIA
  1. H Chappuy1,
  2. A Baruchel2,
  3. F Doz3,
  4. D Davous4,
  5. T Leblanc2,
  6. C Oudot2,
  7. B Brethon5,
  8. M D Tabone2,
  9. J Landman Parker6,
  10. A Auvrignon5,
  11. G Leverger5,
  12. J M Treluyer6
  1. 1Structure d’Urgences Pédiatriques, Hôpital Necker Enfants Malades Assistance Publique Hôpitaux de Paris, EA 3620, Faculté et Université de Médecine Paris Descartes; Laboratoire d’Ethique Médicale Université Paris Descartes, Paris, France
  2. 2Hématologie Pédiatrique, Hôpital Saint-Louis Assistance Publique Hôpitaux de Paris, Université Paris 7, Paris, France
  3. 3Département d’Oncologie Pédiatrique, Institut Curie, Université Paris Descartes, Paris, France
  4. 4Association Apprivoiser l’Absence, Cent Pour Sang la Vie, Paris, France
  5. 5Hématologie-Immunologie-Oncologie Pédiatrique, Hôpital A Trousseau Assistance Publique Hôpitaux de Paris, Université Paris 6, Paris, France
  6. 6Unité de Recherche Clinique Paris Centre; Pharmacologie Hôpital Cochin Saint Vincent de Paul, Assistance Publique Hôpitaux de Paris, EA 3620, Faculté et Université Paris Descartes, Paris, France

Abstract

Objective To evaluate the extent to which parents understand the information they are given when their consent is sought for the participation of their child in a phase III randomised clinical trial, and the reasons for their decision.

Patients and Method We carried out a prospective study, from January 2005 to September 2006. We included all parents whose consent was sought for the participation of their child in the FRALLE 2000 protocol (acute lymphoblastic leukaemia) at two of the participating centres. The parents were questioned twice by a qualified psychologist, using a semi-directed interview, one month and 6 months after their consent was sought.

Results We contacted 51 parents and 43 first interviews were carried out. Thirty-five parents (81%) felt that the information provided with the request for consent was appropriate. Eight parents (19%) did not realise that their child had been included in a research protocol. Sixteen parents (39%) did not understand the concept of randomisation. Half the parents could explain neither the aim of the clinical trial nor the potential benefit of inclusion to their child. Only one third of the parents were aware that they had an alternative. Twenty-two parents (52%) thought that they “had no choice” to participate. Confidence in the medical team was the chief element identified by parents as influencing their choice.

Conclusion Although the parents were satisfied with the information they received, their comprehension was mostly incomplete.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.